CClinicalTrials.gg
CompletedNCT01109901Updated Apr 23, 2010

Comparison of Effect of Anterior Subcutaneous and Submuscular Transposition on Cubital Tunnel Syndrome

A Phase 2 interventional study of anterior subcutaneous transposition and Anterior submuscular transposition in Cubital Tunnel Syndrome, sponsored by Isfahan University of Medical Sciences. Completed at 1 site in Iran, Islamic Republic of. Per ClinicalTrials.gov, last updated 2010-04-23.

Sponsored by Isfahan University of Medical Sciences · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
48
Allocation
Non-randomized
Sex
All
01

Study summary

The purpose of this study is to determine which surgical method is better for cubital tunnel syndrome in outcomes.

Read the detailed description

Compression of the ulnar nerve at the cubital tunnel is the most common cause of numbness on the ulnar side of the hand. We aimed to compare patient outcomes included pain, sensation, muscle strength and muscle atrophy in two methods of surgery contain Anterior Sub Cutaneous Transposition (ASCT) and Anterior Sub Muscular Transposition (ASMT) of the ulnar nerve in Cubital tunnel syndrome.

02

Conditions studied

  • Cubital Tunnel Syndrome

Keywords

  • Cubital tunnel,subcutaneous transposition,submuscular
03

In context

Cubital Tunnel Syndrome

35 studies on the registry are indexed under Cubital Tunnel Syndrome; 7 are open to participants now.

This study's enrollment of 48 is below the median of 63 across 24 interventional studies indexed under Cubital Tunnel Syndrome.

Browse Cubital Tunnel Syndrome studies →

Lead sponsor

Isfahan University of Medical Sciences is the lead sponsor of 145 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients with confirmed cubital tunnel syndrome

Exclusion criteria

Exclusion Criteria:

  • Significant cervical spine and shoulder disease
  • deformity or distortion of the cubital tunnel due to previous trauma to elbow
  • recurrent cubital tunnel syndrome after previous surgery.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
48 participants (actual)

Study arms

  • Other
    anterior submuscular transposition

    it is kind of surgical method

    Procedure: Anterior submuscular transposition

  • Other
    Anterior subcutaneous transposition

    it is kind of surgical method

    Procedure: anterior subcutaneous transposition

Interventions

  • Procedureanterior subcutaneous transposition

    transposition of ulnar nerve into subcutaneous bed

    Also known as: ASCT

  • ProcedureAnterior submuscular transposition

    transposition of ulnar nerve into muscular tissue

    Also known as: ASMT

06

What researchers measure

Primary outcomes

  1. Pain

    Visual Analogue Scale (VAS) with scores of zero to ten (0 for no pain and 10 intolerable pain) then scored as follows: 0, Sever (8-10); 1, Slight (4-7); 2, none (0-3)

    Time frame: at 6 months post-operatively

Secondary outcomes

  1. sensation

    Sensory disturbance were tested with Semmes-Weinstein filaments and sensory deficits were categorized according to the Yale sensory scale. According to standard scoring system that designed, the severity of sensation and function of the ulnar nerve was scored as follows: 0, Abscent sensation; 1, Decrease or abnormal sensation; 2, Intact sensation.

    Time frame: at 6 months post-operatively

  2. Muscle strength

    Muscle strength was evaluated with the grading system from the Medical Research Council which is based upon a scale of zero to five: 0, No muscle contraction; 1,Flicker or trace of muscle contraction; 2,Limb or joint movement possible only with gravity eliminated; 3,Limb or joint movement against gravity only; 4,Power decreased but limb or joint movement possible against resistance; 5,Normal power against resistance. Then results were scored as follows: 0,Poor (0-1); 1,Moderate (2-3); 2,Good (4-5)

    Time frame: at 6 months post-operatively

  3. Muscle atrophy

    Muscle atrophy was scored with one orthopedic surgeon as follows: 0, sever; 1, moderate; 2, none

    Time frame: at 6 months post-operatively

07

Study locations

1 site
  • Al-zahra university hospital
    Isfahan, 70007, Iran, Islamic Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01109901
Lead sponsor
Isfahan University of Medical Sciences
First posted
Apr 23, 2010
Start date
Oct 2008
Primary completion
Mar 2009
Completion
Mar 2009
Last update
Apr 23, 2010

Study contacts

hamidreza Shemshaki, MD
study chair · MD,research comittee

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion